| FXAIX | RFNCX | FXAIX / RFNCX | |
| Total Expense Ratio | 0.01 | 0.93 | 2% |
| Annual Report Gross Expense Ratio | 0.01 | 0.93 | 2% |
| Fund Existence | 15 years | 24 years | - |
| Gain YTD | 12.437 | 12.893 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 833B | 178B | 468% |
| Annual Yield % from dividends | 1.06 | 0.31 | 337% |
| Returns for 1 year | 21.35 | 16.89 | 126% |
| Returns for 3 years | 81.15 | 56.52 | 144% |
| Returns for 5 years | 84.67 | 37.83 | 224% |
| Returns for 10 years | 286.57 | 96.75 | 296% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HLMOX | 9.72 | 0.10 | +1.04% |
| Harding Loevner Frontier Emerg Mkts Inv | |||
| GGHYX | 44.29 | 0.43 | +0.98% |
| Invesco Health Care Y | |||
| PRJDX | 37.71 | 0.17 | +0.45% |
| PGIM Jennison Global Opportunities R4 | |||
| TRSAX | 104.37 | 0.38 | +0.37% |
| T. Rowe Price Growth Stock Adv | |||
| IUAIX | 34.44 | N/A | N/A |
| VY® Invesco Equity and Income I | |||